Does needle size matter?

Journal of Diabetes Science and Technology

Volumn 1, Issue 5, 2007, Pages 725-729

  Gill, Harvinder S ^a   Prausnitz, Mark R ^a,b  

^a Emory University   (United States)

^b Georgia Institute of Technology   (United States)

Author keywords

Drug delivery; Hypodermic needle; Insulin delivery methods; Microneedle injection; Needle gauge; Needle length; Pain from needle insertion

Indexed keywords

EID: 78751648781     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680700100517     Document Type: Article

References (30)

1. Kravetz RE. Hypodermic syringe. Am J Gastroenterol. 2005 Dec; 100(12):2614-5.
2. Hauri A, Armstrong G, Hutin Y. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS. 2004 Jan; 15(1):7-16.
3. Lindh WQ. Delmar's comprehensive medical assisting: administrative and clinical competencies. Albany (NY): Delmar Health Care Publishing; 1998.
4. Kroger A, Atkinson W, Marcuse E, Pickering L. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 55 (RR-15). Centers for Disease Control and Prevention, Atlanta, GA; 2006.
5. Schwartz S, Hassman D, Shelmet J, Sievers R, Weinstein R, Liang J, Lyness W. A multicenter, open-label, randomized, twoperiod crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge x 6 mm needle versus a 29 gauge x 12.7 mm needle in obese patients with diabetes mellitus. Clin Ther. 2004 Oct; 26(10):1663-78.
6. Deacon B, Abramowitz J. Fear of needles and vasovagal reactions among phlebotomy patients. J Anxiety Disord. 2006;20(7):946-60.
7. Hanas R. Reducing injection pain in children and adolescents with diabetes: a review of indwelling catheters. Pediatr Diabetes. 2004 Jun; 5(2):102-11.
8. Berlin I, Bisserbe JC, Eiber R, Balssa N, Sachon C, Bosquet F, Grimaldi A. Phobic symptoms, particularly the fear of blood and injury, are associated with poor glycemic control in type I diabetic adults. Diabetes Care. 1997 Feb; 20(2):176-8.
9. Arendt-Nielsen L, Egekvist H, Bjerring P. Pain following controlled cutaneous insertion of needles with different diameters. Somatosens Mot Res. 2006 Mar-Jun; 23(1-2):37-43.
10. Egekvist H, Bjerring P, Arendt-Nielsen L. Pain and mechanical injury of human skin following needle insertions. Eur J Pain. 1999 Mar; 3(1):41-49.
11. Egekvist H, Bjerring P, Arendt-Nielsen L. Regional variations in pain to controlled mechanical skin traumas from automatic needle insertions and relations to ultrasonography. Skin Res Technol. 1999;247-54.
12. Schneider LW, Peck LS, Melvin JW. Penetration characteristics of hypodermic needles in skin and muscle tissue. Phase I (Appendices B-E). Final report. Highway Safety Research Institute, Ann Arbor, MI; 1978. Persistent URL http://hdl.handle.net/2027.42/614
13. ® 33-gauge needle for insulin therapy. J Diabetes Sci Technol. 2007;1(5):718-724.
14. Alarcon JB, Hartley AW, Harvey NG, Mikszta JA. Preclinical evaluation of microneedle technology for intradermal delivery of infuenza vaccines. Clin Vaccine Immunol. 2007 Apr; 14(4):375-81.
15. Mikszta JA, Sullivan VJ, Dean C, Waterston AM, Alarcon JB, Dekker JP 3rd, Brittingham JM, Huang J, Hwang CR, Ferriter M, Jiang G, Mar. K, Saikh KU, Stiles BG, Roy CJ, Ulrich RG, Harvey NG. Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. J Infect Dis. 2005 Jan 15;191(2):278-88.
16. Braverman IM. The cutaneous microcirculation. J Invest Dermatol Symp Proc. 2000;5:3-9.
17. Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004 Feb; 3(2):115-24.
18. Prausnitz M, Mikszta J, Raeder-Devens J. Microneedles. In: Smith EW, H. I. Maibach HI, editors. Percutaneous penetration enhancers. Boca Raton (FL): CRC Press; 2005. p. 239-55.
19. Davis SP, Martanto W, Allen MG, Prausnitz MR. Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans Biomed Eng. 2005 May; 52(5):909-15.
20. Gardeniers H J G E, Luttge R, Berenschot E J W, De Boer MJ, Yeshurun SY, Hefetz M, Van't Oever R, Van Den Berg A. Silicon micromachined hollow microneedles for transdermal liquid transport. J MEMS. 2003;12:855-62.
21. Nordquist L, Roxhed N, Griss P, Stemme G. Novel microneedle patches for active insulin delivery are efficient in maintaining glycaemic control: an initial comparison with subcutaneous administration. Pharm Res. 2007 Jul; 24(7):1381-8.
22. Gupta J, Felner E, Prausnitz MR. Microneedles for minimally invasive transdermal insulin delivery: an in vivo study in human diabetic subjects. Proceedings of the 6th Annual Diabetes Technology Meeting; 2006.
23. Kaushik S, Hord AH, Denson DD, McAllister DV, Smitra S, Allen MG, Prausnitz MR. Lack of pain associated with microfabricated microneedles. Anesth Analg. 2001 Feb; 92(2):502-4.
24. Bohannon NJ. Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med. 1999 Oct. 15;106(5):57-64.
25. Davis SP, Landis BJ, Adams ZH, Allen MG, Prausnitz MR. Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. J Biomech. 2004 Aug; 37(8):1155-63.
26. Yang M, Zahn JD. Microneedle insertion force reduction using vibratory actuation. Biomed Microdevices. 2004 Sep; 6(3):177-82.
27. Mitragotri S. Current status and future prospects of needle-free liquid jet injectors. Nat Rev Drug Discov. 2006 Jul; 5(7):543-8.
28. Cross SE, Roberts MS. Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development? Curr Drug Deliv. 2004 Jan; 1(1):81-92.
29. Touitou E, Barry BW, editors. Enhancement in drug delivery. Boca Raton (FL): CRC Press; 2006.
30. Jani R, Triplitt C, Reasner C, Defronzo RA. First approved inhaled insulin therapy for diabetes mellitus. Expert Opin Drug Deliv. 2007 Jan; 4(1):63-76.